Effects of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism on executive function in schizophrenia

Schizophrenia Research

Volumn 92, Issue 1-3, 2007, Pages 181-188

  Roffman, Joshua L ^a   Weiss, Anthony P ^a   Deckersbach, Thilo ^a   Freudenreich, Oliver ^a   Henderson, David C ^a   Purcell, Shaun ^a   Wong, Donna H ^b   Halsted, Charles H ^b   Goff, Donald C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Executive function; MTHFR; Negative symptoms; Path analysis; Schizophrenia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ARTICLE; COGNITION; DEMOGRAPHY; DISEASE DURATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; NEUROPSYCHOLOGICAL TEST; PATH ANALYSIS; PRIORITY JOURNAL; RISK; SCHIZOPHRENIA; STATISTICAL ANALYSIS; WISCONSIN CARD SORTING TEST;

ADULT; AFFECT; COGNITION DISORDERS; FEMALE; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; VERBAL BEHAVIOR; VERBAL LEARNING;

EID: 34147138840     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.01.003     Document Type: Article

References (34)

1. Appels M.C., Sitskoorn M.M., Westers P., Lems E., and Kahn R.S. Cognitive dysfunctions in parents of schizophrenic patients parallel the deficits found in patients. Schizophr. Res. 63 3 (2003) 285-293
2. Baron R.M., and Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 51 6 (1986) 1173-1182
3. Benton A.L., and Hamsher K.D. Multilingual Aphasia Examination (1989), AJA Associates, Iowa City
4. Berg E.A. A simple objective treatment for measuring flexibility in thinking. J. Gen. Psych. 39 (1948) 15-22
5. Callicott J.H., Straub R.E., Pezawas L., Egan M.F., Mattay V.S., Hariri A.R., Verchinski B.A., Meyer-Lindenberg A., Balkissoon R., Kolachana B., Goldberg T.E., and Weinberger D.R. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 102 24 (2005) 8627-8632
6. Delis D.C., Kraemer J.H., Kaplan E., and Ober B.A. California Verbal Learning Test: Adult Version (1987), The Psychological Corporation, San Antonio
7. Egan M.F., Goldberg T.E., Gscheidle T., Weirich M., Bigelow L.B., and Weinberger D.R. Relative risk of attention deficits in siblings of patients with schizophrenia. Am. J. Psychiatry 157 8 (2000) 1309-1316
8. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., and Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98 12 (2001) 6917-6922
9. Elliott G.R., Sutherland K., Erdelyi E., Ciaranello R.D., Barchas J.D., and Wyatt R.J. N5,10-methylenetetrahydrofolate reductase activity in autopsied brain parts of chronic schizophrenics and controls and in vitro tryptoline formation. Biol. Psychiatry 13 6 (1978) 695-708
10. Freeman J.M., Finkelstein J.D., and Mudd S.H. Folate-responsive homocystinuria and "schizophrenia". A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity. N. Engl. J. Med. 292 10 (1975) 491-496
11. Friso S., Choi S.W., Girelli D., Mason J.B., Dolnikowski G.G., Bagley P.J., Olivieri O., Jacques P.F., Rosenberg I.H., Corrocher R., and Selhub J. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl. Acad. Sci. U. S. A. 99 8 (2002) 5606-5611
12. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., van den Heuvel L.P., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10 1 (1995) 111-113
13. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
14. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., and Weinberger D.R. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 23 17 (2003) 6690-6694
15. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 1 (2005) 40-68
16. Harvey P.D., Koren D., Reichenberg A., and Bowie C.R. Negative symptoms and cognitive deficits: what is the nature of their relationship?. Schizophr. Bull. 32 2 (2006) 250-258
17. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., and Curtiss G. Wisconsin Card Sorting Test manual (Revised and expanded) (1993), Psychological Assessment Resources, Odessa
18. Heinrichs R.W., and Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12 3 (1998) 426-445
19. Henry J.D., and Crawford J.R. A meta-analytic review of verbal fluency deficits in schizophrenia relative to other neurocognitive deficits. Cogn. Neuropsychiatry 10 1 (2005) 1-33
20. Hill S.K., Beers S.R., Kmiec J.A., Keshavan M.S., and Sweeney J.A. Impairment of verbal memory and learning in antipsychotic-naive patients with first-episode schizophrenia. Schizophr. Res. 68 2-3 (2004) 127-136
21. Ho B.C., Wassink T.H., O'Leary D.S., Sheffield V.C., and Andreasen N.C. Catechol-O- methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Mol. Psychiatry 10 3 (2005) 229, 287-229, 298
22. Jacques P.F., Bostom A.G., Williams R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H., Selhub J., and Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93 1 (1996) 7-9
23. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13 2 (1987) 261-276
24. Keku T., Millikan R., Worley K., Winkel S., Eaton A., Biscocho L., Martin C., and Sandler R. 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol. Biomark. Prev. 11 12 (2002) 1611-1621
25. Kraemer H.C., Stice E., Kazdin A., Offord D., and Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am. J. Psychiatry 158 6 (2001) 848-856
26. Laws K.R. A meta-analytic review of Wisconsin Card Sort studies in schizophrenia: general intellectual deficit in disguise?. Cogn. Neuropsychiatry 4 1 (1999) 1-30 (discussion 31-35)
27. Lewis S.J., Zammit S., Gunnell D., and Smith G.D. A meta-analysis of the MTHFR C677T polymorphism and schizophrenia risk. Am. J. Med. Genet., B Neuropsychiatr. Genet. 135 1 (2005) 2-4
28. McGurk S.R., Coleman T., Harvey P.D., Reichenberg A., White L., Friedman J., Parrella M., and Davis K.L. Working memory performance in poor outcome schizophrenia: relationship to age and executive functioning. J. Clin. Exp. Neuropsychol. 26 2 (2004) 153-160
29. Paulsen J.S., Heaton R.K., Sadek J.R., Perry W., Delis D.C., Braff D., Kuck J., Zisook S., and Jeste D.V. The nature of learning and memory impairments in schizophrenia. J. Int. Neuropsychol. Soc. 1 1 (1995) 88-99
30. Roffman, J.L., Weiss, A.P., Purcell, S., Caffalette, C.A., Freudenreich, O., Henderson, D.C., Bottiglieri, T., Wong, D.H., Halsted, C.H.,Goff, D.C., in press. Contribution of methylenetetrahyrdofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia. Biol. Psychiatry.
31. Sharma T., and Antonova L. Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment. Psychiatr. Clin. North Am. 26 1 (2003) 25-40
32. Simpson G.M., and Angus J.W. A rating scale for extrapyramidal side effects. Acta Psychiatr., Scand. Suppl. 212 (1970) 11-19
33. Stricker J.L., Brown G.G., Wixted J., Baldo J.V., and Delis D.C. New semantic and serial clustering indices for the California Verbal Learning Test-Second Edition: background, rationale, and formulae. J. Int. Neuropsychol. Soc. 8 3 (2002) 425-435
34. Wechsler D. Wechsler Adult Intelligence Scale-Third Edition (1997), Harcourt Assessment, Inc., San Antonio